Boditech Med Inc. (KOSDAQ:206640)
11,420
+280 (2.51%)
Apr 10, 2026, 3:30 PM KST
Boditech Med Revenue
In the year 2025, Boditech Med had annual revenue of 162.09B KRW with 17.32% growth. Boditech Med had revenue of 41.57B in the quarter ending December 31, 2025, with 33.12% growth.
Revenue
162.09B
Revenue Growth
+17.32%
P/S Ratio
1.43
Revenue / Employee
299.62M
Employees
541
Market Cap
232.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 162.09B | 23.93B | 17.32% |
| Dec 31, 2024 | 138.16B | 3.94B | 2.94% |
| Dec 31, 2023 | 134.22B | 16.14B | 13.67% |
| Dec 31, 2022 | 118.08B | -39.63B | -25.13% |
| Dec 31, 2021 | 157.71B | 13.58B | 9.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chong Kun Dang Holdings | 959.01B |
| Suheung | 722.31B |
| Daewon Pharmaceutical | 605.43B |
| Samjin Pharmaceuticals | 274.03B |
| Ilyang Pharmaceutical Co.,Ltd | 272.42B |
| JW Lifescience | 257.83B |
| Whan In Pharm | 255.21B |
| Samil Pharmaceutical Co.,Ltd | 210.25B |